EMD-32491

Single-particle
3.5 Å
EMD-32491 Deposition: 29/12/2021
Map released: 04/01/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-32491

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7wgx summary report (pdf.gz) Map-7wgx FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L

EMD-32491

Single-particle
3.5 Å
EMD-32491 Deposition: 29/12/2021
Map released: 04/01/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer
Fitted models: 7wgx

Deposition Authors: Zhu Y, Tai L
Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies
DOI: doi:10.1038/s41421-022-00419-w
ISSN: 2056-5968
Grant Support: